CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-16 | GRIFFITH MELINDA Director | Purchase | +10,000 | $1.00 | $10K | 30,000 |
| 2022-08-15 | GRIFFITH MELINDA Director | Grant or award | +10,000 | 20,000 | ||
| 2022-08-15 | GRIFFITH MELINDA Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2022-06-24 | GRIFFITH MELINDA Director | Option exercise | +10,000 | 10,000 | ||
| 2022-06-24 | GRIFFITH MELINDA Director | Option exercise · Restricted Stock Units | −10,000 | 0 | ||
| 2021-06-24 | GRIFFITH MELINDA Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | GRIFFITH MELINDA Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2020-06-17 | GRIFFITH MELINDA Director | Grant or award · Option to purchase common stock | +57,000 | 57,000 |
Page 1 of 1 · 8 trades